Welcome to Prostap DCS
This page provides information about the conditions Prostap DCS can be used to treat, including links to charities that can provide more information.
About Prostap DCS
Prostap DCS is used to treat a variety of different conditions, including:
- Prostate cancer
- Breast cancer
- Endometriosis
- Central precocious puberty
This treatment may be referred to as Prostap DCS, the brand name, or leuprorelin acetate, the active ingredient in the medicine.
Please speak to your healthcare professional if you have any questions or concerns about any of these conditions. Further information about Prostap DCS can be found via the Patient Information Leaflets and Summary of Product Characteristics links below.
Prostap SR DCS
Prostap PD DCS
What is prostate cancer?
Prostate cancer occurs when prostate cells begin to malfunction – they respond to normal levels of testosterone by growing faster and in an uncontrolled way.
Visit the links below for more information on prostate cancer:
-
NHS website: nhs.uk/conditions/prostate-cancer/
-
Prostate Cancer UK: prostatecanceruk.org/
-
Cancer Research UK: cancerresearchuk.org/about-cancer/prostate-cancer
What is breast cancer?
Breast cancer occurs when abnormal cells in the breast begin to grow and divide in an uncontrolled way and eventually form a tumour.
Visit the links below to charities and organisations that support patients and those affected by breast cancer:
-
NHS website – breast cancer in women: nhs.uk/conditions/breast-cancer-in-women/
NHS website – breast cancer in men: nhs.uk/conditions/breast-cancer-in-men/
-
Breast Cancer Now: https://breastcancernow.org/
-
Cancer Research UK: cancerresearchuk.org/about-cancer/breast-cancer
What is Endometriosis?
Endometriosis is a condition where tissue similar to the lining of the uterus grows in other places, such as the ovaries and fallopian tubes.
Visit the links below to charities and organisations that support patients and those affected by endometriosis:
-
NHS website: nhs.uk/conditions/endometriosis/
-
Endometriosis UK: endometriosis-uk.org/
-
The Endometriosis Foundation: theendometriosisfoundation.org/
What is central precocious puberty?
Central precocious puberty is a condition that causes an early onset of puberty in children: before 9 years of age in girls and 10 in boys.
Visit the link below to the NHS page that supports patients and those affected by central precocious puberty:
-
NHS website: nhs.uk/conditions/early-or-delayed-puberty/
DCS=dual-chamber syringe
You are now leaving Prostapdcs.co.uk. Takeda reviews the accuracy and content of its products that are available via the link you have selected. However, Takeda are not the owners of the website and as such do not control the overall running of the website or any non-Takeda-related content.
Please confirm if you wish to follow this link.
Contact us
If you are a healthcare professional and have a query about Prostap DCS, please contact Medical Information on:
If you are a healthcare professional and would like to be contacted about Prostap DCS, please enter your details in the short form below
References
You are now leaving prostapdcs.co.uk. Takeda are the owners of the following website and control the overall running of the website and Takeda-related content.
Please confirm if you wish to follow this link.